<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rasheduzzaman M</submitter><funding>Chamindie Punyadeera</funding><funding>Mohammad Rasheduzzaman</funding><funding>Daniel Kolarich</funding><funding>Griffith University</funding><pagination>8401-8411</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9712327</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>414(29-30)</volume><pubmed_abstract>Glycosylation is the most common post-translational modification of proteins, and glycosylation changes at cell surfaces are frequently associated with malignant epithelia including head and neck squamous cell carcinoma (HNSCC). In HNSCC, 5-year survival remains poor, averaging around 50% globally: this is partly related to late diagnosis. Specific protein glycosylation signatures on malignant keratinocytes have promise as diagnostic and prognostic biomarkers and as therapeutic targets. Nevertheless, HNSCC-specific glycome is to date largely unknown. Herein, we tested six established HNSCC cell lines to capture the qualitative and semi-quantitative N-glycome using porous graphitized carbon liquid chromatography coupled to electrospray ionisation tandem mass spectrometry. Oligomannose-type </pubmed_abstract><journal>Analytical and bioanalytical chemistry</journal><pubmed_title>Head and neck cancer N-glycome traits are cell line and HPV status-dependent.</pubmed_title><pmcid>PMC9712327</pmcid><funding_grant_id>Medical Research Future Fund (MRFF)</funding_grant_id><funding_grant_id>Cancer Australia (APP1145657)</funding_grant_id><funding_grant_id>Australian Government Research Training Program</funding_grant_id><funding_grant_id>Medical Research Council</funding_grant_id><funding_grant_id>Australian Government grant by project CE140100003</funding_grant_id><funding_grant_id>Australian Research Council Future Fellowship</funding_grant_id><funding_grant_id>National Health</funding_grant_id><pubmed_authors>Dolcetti R</pubmed_authors><pubmed_authors>Murugan AVM</pubmed_authors><pubmed_authors>Kolarich D</pubmed_authors><pubmed_authors>Kenny L</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Oliveira T</pubmed_authors><pubmed_authors>Johnson NW</pubmed_authors><pubmed_authors>Punyadeera C</pubmed_authors><pubmed_authors>Rasheduzzaman M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Head and neck cancer N-glycome traits are cell line and HPV status-dependent.</name><description>Glycosylation is the most common post-translational modification of proteins, and glycosylation changes at cell surfaces are frequently associated with malignant epithelia including head and neck squamous cell carcinoma (HNSCC). In HNSCC, 5-year survival remains poor, averaging around 50% globally: this is partly related to late diagnosis. Specific protein glycosylation signatures on malignant keratinocytes have promise as diagnostic and prognostic biomarkers and as therapeutic targets. Nevertheless, HNSCC-specific glycome is to date largely unknown. Herein, we tested six established HNSCC cell lines to capture the qualitative and semi-quantitative N-glycome using porous graphitized carbon liquid chromatography coupled to electrospray ionisation tandem mass spectrometry. Oligomannose-type </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-05-05T02:50:37.728Z</modification><creation>2025-04-06T04:50:13.582Z</creation></dates><accession>S-EPMC9712327</accession><cross_references><pubmed>36289103</pubmed><doi>10.1007/s00216-022-04376-x</doi></cross_references></HashMap>